As America’s first eye specialty hospital, founded in 1820, the Department of Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai (NYEE) is one of the world’s leading facilities for the most advanced surgical and micro-interventional procedures, as well as the latest diagnostic and therapeutic services aimed at delivering sight-saving interventions, safely and quickly. In addition to being at the forefront of innovative surgical specialty care, NYEE is home to the largest residency program in the US and also serves as the clinical site for breakthrough translational research with a network of satellite practices across the New York metropolitan area. The Department of Ophthalmology at NYEE is ranked No. 12 nationally (highest in NYC) by the U.S. News & World Report 2022-23 rankings.
Find us here: https://www.nyee.edu/care/eye/locations, or call 212-979-4500.
As America’s first eye specialty hospital, founded in 1820, the Department of Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai (NYEE) is one of the world’s leading facilities for the most advanced surgical and micro-interventional procedures, as well as the latest diagnostic and therapeutic services aimed at delivering sight-saving interventions, safely and quickly. In addition to being at the forefront of innovative surgical specialty care, NYEE is home to the largest residency program in the US and also serves as the clinical site for breakthrough translational research with a network of satellite practices across the New York metropolitan area. The Department of Ophthalmology at NYEE is ranked No. 12 nationally (highest in NYC) by the U.S. News & World Report 2022-23 rankings.
Find us here: https://www.nyee.edu/care/eye/locations, or call 212-979-4500.
Latest Videos | View More >
Video
NYEE Pioneers the First Clinical Robotic Interventional System for Ocular Surgery in America
New York Eye and Ear Infirmary of Mount Sinai (NYEE) is ushering in a new era of ophthalmic surgery with the first robotic interventional system in America, which will revolutionize the delivery of sight-saving therapies
Video
NYEE Is Reimagining Telemedicine for a New Era of Patient Care
From teleconsults in the emergency department to onsite fundus imaging at primary care offices, New York Eye and Ear Infirmary of Mount Sinai (NYEE) is adapting to the rapidly changing health care environment with innovative new applications and technologies
Video
Ophthalmology Residency at New York Eye and Ear Infirmary of Mount Sinai
Gain an overview of the Ophthalmology Residency program at New York Eye and Ear Infirmary of Mount Sinai, which offers a competitive training environment rooted in practice-based learning, exposure to challenging clinical cases, surgical ...
Video
NYEE: Past, Present, and the Future
The world-class faculty at New York Eye and Ear Infirmary of Mount Sinai (NYEE) discuss the development and application of the latest research and technologies that are advancing ophthalmology by revolutionizing patient care, vision science, and education
Video
COVID-19: Impact on Eye Health
Gareth M.C. Lema, MD, PhD, answers questions regarding COVID-19 transmission through the eyes, and other eye-health concerns.
Video
Retinal Imaging and Management of Diabetic Retinopathy
Gareth Lema, MD, PhD, discusses diagnostic imaging technology and treatment for diabetic retinopathy in this Grand Rounds presentation
Featured Content
Document
The following two articles demonstrate how that commitment has evolved in the key areas of technology and training.
Document
Ophthalmic Pathology Referral Service at New York Eye and Ear Infirmary of Mount Sinai
The Ophthalmic Pathology Referral Service at New York Eye and Ear Infirmary of Mount Sinai is meeting a critical need for ophthalmic pathology services regionally and nationally
Document
When a person suffers a central retinal artery occlusion (CRAO), time is of the essence. CRAO is the ocular equivalent of a cerebral stroke, and like a stroke, emergent treatment is necessary to prevent permanent retinal damage and vision loss.
News
Two Distinct Pathways Are Identified for Age-Related Macular Degeneration
Researchers have shed a new light into understanding the links between advanced age-related macular degeneration, cardiovascular disease, and stroke.
News
Surgeons at NYEE and Mount Sinai Team Up for a Five-Year-Old Patient
Technology and surgical skills come together as surgeons team up to repair an arteriovenous malformation in the orbit compressing the optic nerve.
News
The planned state-of-the-art ASC reflects a partnership between NYEE, Mount Sinai Ambulatory Ventures, our community physicians, and Merritt Healthcare.
News
Researchers Target a Major Hurdle for Retinal Stem Cell Replacement
Researchers have discovered a potential way around the production of epiretinal membranes, a major adverse event in the use of induced pluripotent stem cells, to treat AMD.
News
New Imaging Shows First-Time Evidence of Vaso-Occlusion Dynamics in Sickle Cell Disease
Mount Sinai researchers reveal cellular phenomena of sickle cell capillary blood flow in extraordinary detail, opening the door to earlier diagnosis and individualized treatment.
News
A New Industry Partner Is a Milestone for Ophthalmic Robotics
The recent acquisition of Preceyes by industry leader ZEISS Medical, will further advance the field of microsurgical robotics.
Document
In this issue, we take a closer look at one of NYEE’s esteemed physicians, Paul Finger, MD, FACS, and his pioneering work in the field of ocular cancer, which has had a profound impact on current treatment modalities and their outcomes.
Document
NYEE’s Ocular Oncology Service Expanded Patient Options for Eye Cancer Treatment
The Ocular Oncology Service at NYEE is home to the most advanced forms of eye cancer treatments aimed at preserving life, preserving the eye, and saving sight
Document
NYEE-Mount Sinai Eye Stroke Protocol Saves a Young Woman’s Sight
Treatment of acute eye stroke with intra-arterial tPA is showing great promise
News
Science is one step closer to developing effective cell therapy to treat blindness. Mount Sinai’s researchers recently published paper found that retinal cells from a human cadaver’s eye could be successfully transplanted into primate ...
Document
Taking Retinal Imaging to the Cellular Level Helps Treat Intra-Retinal Diseases
New York Eye and Ear Infirmary of Mount Sinai (NYEE) is at the forefront of imaging research into glaucoma, macular degeneration, and other intra-retinal diseases with the development of a super-fast, 1.64 MHz OCTA system
Document
New Retinal Capillary Density Mapping Technique Could Provide an Advanced Window on Disease
NYEE is a global leader in ocular imaging. Leveraging our experience in adaptive optics vascular analysis, to create software tools to help predict onset of ocular diseases, we are turning OCTA imaging into a practical tool for clinicians...
Document
An Unprecedented Look at Acute Solar Retinopathy
New York Eye and Ear Infirmary of Mount Sinai’s ability to marry AO with other advanced technologies like OCT angiography and en face OCT, sheds new light on damage caused to the retina by solar eclipse
Document
Breaking New Ground in Gene Transfer Therapy to Restore Vision
The Department of Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai (NYEE) is breaking new ground in the field of retinal regeneration to potentially restore visual function in people with degenerative glaucoma, macular degeneration...
News
New York Eye and Ear Infirmary of Mount Sinai (NYEE) Specialty Report 2021
Fresh off our bicentennial year, the New York Eye and Ear Infirmary of Mount Sinai immediately began writing the next chapter of our storied history with a narrative driven by the prominent role of technology, research, and education in ...
News
New York Eye & Ear Infirmary of Mount Sinai: 2020 Chair Report
New York Eye and Ear Infirmary’s (NYEE) 200-year journey has not been an easy one. Wars, pandemics, and financial meltdowns: we have seen and endured them all.
